Preparing stock dashboard...
Preparing stock dashboard...
T14.SI - SES
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1915 and is based in Tianjin, the People's Republic of China.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited trades as T14.SI on SES. Its latest stored price is $3.05 as of June 8, 2026.
Data updated June 8, 2026
| Metric | Value ('000,000) |
|---|
Scores this stock using the same metrics model as the compare page.
| Metric | Value | Score |
|---|
Mouse wheel or pinch to zoom. Drag chart to pan. Double-click to reset zoom.